Results 201 to 210 of about 8,964,280 (317)

Is the early or delayed remote ischemic preconditioning the more effective from a microcirculatory and histological point of view in a rat model of partial liver ischemia-reperfusion?

, 2018
Zsuzsanna Magyar, Gábor Varga, Anita Mester, Souleiman Ghanem, Viktória Somogyi, Bence Tánczos, Ádám Deák, László Bidiga, Katalin Pető, Norbert Németh   +9 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Truth-Telling to Palliative Care Patients from the Relatives' Point of View: A Türkiye Sample. [PDF]

Healthcare (Basel)
Kıraç Utku İ, Şengür E.
europepmc   +1 more source

F-004. View point of the clinician — O. Coll (Barcelona, Spain) [PDF]

, 1999

openalex   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon, Peter T. Gallagher, Orly I. Richter, Neermala Poudel Neupane, Amy C. Mandigo, Jennifer J. McCann, Emanuela Dylgjeri, Irina Vasilevskaya, Christopher McNair, Channing J. Paller, Wm. Kevin Kelly, Karen E. Knudsen, Matthew J. Schiewer, Ayesha A. Shafi   +13 more
wiley   +1 more source

Bowel Preparation for Colonoscopy: The Patient Point of View.

Dig Dis
Tontini G, Spada C, Radaelli F, Testoni PA, Ciprandi G, Vecchi M.   +5 more
europepmc   +1 more source

Hypersensitivity Reactions to Gadolinium-Based Contrast Agents: Update From an Allergist's Point of View. [PDF]

Clin Transl Allergy
Losa F, Paoletti G, Costanzo G, Rizzini FL, Mauro M, Preziosi D, Rivolta F, Sangalli A, Toniato A, Traversi S, Vrenna A, Di Gioacchino M, Canonica GW, Heffler E, Costantino MT.   +14 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

A <i>heretical</i> point of view in masonry structures dynamics. [PDF]

R Soc Open Sci
Argenziano M, Babilio E, Ikeda Y, Fraldi M.   +3 more
europepmc   +1 more source

Project title: Modern animal husbandry is regarded from different societal point of views to encourage a reduction of the gap between today´s agriculture and the society

, 2019
Unknown
openalex